Endo is an Ireland-based pharmaceutical company that researches, develops, and commercializes therapeutics for the treatment of genetic disorders and kidney diseases.
Business Model:
Revenue: $2.6B
Employees: 1,001-5,000
Address: Simmonscourt Road
City: Ballsbridge
State: county dublin
Zip:
Country: IE
Endo is an Ireland-based pharmaceutical company that researches, develops, and commercializes therapeutics for the treatment of genetic disorders and kidney diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/14/2014
Ticker Symbol:
ENDP
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
10/2020 | BioSpecifics Technologies | |
5/2015 | Par Pharmaceuticals | |
9/2014 | Auxilium Pharmaceuticals | |
8/2014 | DAVA Pharmaceuticals | |
4/2014 | Somar | |
2/2014 | Paladin Labs | |
9/2013 | Litha Healthcare Group | |
6/2011 | American Medical Systems | |
9/2010 | Qualitest Pharmaceuticals | |
8/2010 | Penwest Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|